Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Simultaneous pathological findings in biopsy specimens of patients with surgically resected lung carcinoids and their role in survival.
Georgakopoulou VE, Zygouris E, Papalexis P, Gkoufa A, Damaskos C, Pierrakou A, Mantzouranis K, Chlapoutakis S, Aravantinou-Fatorou A, Sklapani P, Trakas N, Janinis J, Dahabreh J, Spandidos DA. Georgakopoulou VE, et al. Among authors: dahabreh j. Oncol Lett. 2022 Jul 15;24(3):313. doi: 10.3892/ol.2022.13433. eCollection 2022 Sep. Oncol Lett. 2022. PMID: 35949610 Free PMC article.
Prognostic value of the immunohistochemistry markers CD56, TTF-1, synaptophysin, CEA, EMA and NSE in surgically resected lung carcinoid tumors.
Georgakopoulou VE, Zygouris E, Damaskos C, Pierrakou A, Papalexis P, Garmpis N, Aravantinou-Fatorou A, Chlapoutakis S, Diamantis E, Nikokiris C, Gkoufa A, Sklapani P, Trakas N, Janinis J, Spandidos DA, Dahabreh J. Georgakopoulou VE, et al. Among authors: dahabreh j. Mol Clin Oncol. 2022 Feb;16(2):31. doi: 10.3892/mco.2021.2464. Epub 2021 Dec 14. Mol Clin Oncol. 2022. PMID: 34984102 Free PMC article.
Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial.
Vansteenkiste JF, Cho BC, Vanakesa T, De Pas T, Zielinski M, Kim MS, Jassem J, Yoshimura M, Dahabreh J, Nakayama H, Havel L, Kondo H, Mitsudomi T, Zarogoulidis K, Gladkov OA, Udud K, Tada H, Hoffman H, Bugge A, Taylor P, Gonzalez EE, Liao ML, He J, Pujol JL, Louahed J, Debois M, Brichard V, Debruyne C, Therasse P, Altorki N. Vansteenkiste JF, et al. Among authors: dahabreh j. Lancet Oncol. 2016 Jun;17(6):822-835. doi: 10.1016/S1470-2045(16)00099-1. Epub 2016 Apr 27. Lancet Oncol. 2016. PMID: 27132212 Clinical Trial.
Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients.
Papadopoulou E, Tsoulos N, Tsirigoti A, Apessos A, Agiannitopoulos K, Metaxa-Mariatou V, Zarogoulidis K, Zarogoulidis P, Kasarakis D, Kakolyris S, Dahabreh J, Vlastos F, Zoublios C, Rapti A, Papageorgiou NG, Veldekis D, Gaga M, Aravantinos G, Karavasilis V, Karagiannidis N, Nasioulas G. Papadopoulou E, et al. Among authors: dahabreh j. Oncol Lett. 2015 Oct;10(4):2176-2184. doi: 10.3892/ol.2015.3600. Epub 2015 Aug 12. Oncol Lett. 2015. PMID: 26622815 Free PMC article.
Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results.
Vansteenkiste J, Zielinski M, Linder A, Dahabreh J, Gonzalez EE, Malinowski W, Lopez-Brea M, Vanakesa T, Jassem J, Kalofonos H, Perdeus J, Bonnet R, Basko J, Janilionis R, Passlick B, Treasure T, Gillet M, Lehmann FF, Brichard VG. Vansteenkiste J, et al. Among authors: dahabreh j. J Clin Oncol. 2013 Jul 1;31(19):2396-403. doi: 10.1200/JCO.2012.43.7103. Epub 2013 May 28. J Clin Oncol. 2013. PMID: 23715567 Clinical Trial.
Mouse p53-deficient cancer models as platforms for obtaining genomic predictors of human cancer clinical outcomes.
Dueñas M, Santos M, Aranda JF, Bielza C, Martínez-Cruz AB, Lorz C, Taron M, Ciruelos EM, Rodríguez-Peralto JL, Martín M, Larrañaga P, Dahabreh J, Stathopoulos GP, Rosell R, Paramio JM, García-Escudero R. Dueñas M, et al. Among authors: dahabreh j. PLoS One. 2012;7(8):e42494. doi: 10.1371/journal.pone.0042494. Epub 2012 Aug 7. PLoS One. 2012. PMID: 22880004 Free PMC article.
hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment.
Vageli DP, Zaravinos A, Daniil Z, Dahabreh J, Doukas SG, Spandidos DA, Gourgoulianis KI, Koukoulis GK. Vageli DP, et al. Among authors: dahabreh j. Int J Biol Markers. 2013 Jan 27;27(4):e400-4. doi: 10.5301/JBM.2012.9420. Int J Biol Markers. 2013. PMID: 22865300 Free article.
26 results